Wednesday, 08 January 2025

Main

Information
Last updated: 04 January 2025 Print

Centronuclear Myopathies (CNMs)

Information
Centronuclear MyopathiesCongenital Myopathies

Overview

  • Centronuclear myopathies (CNMs): A group of congenital myopathies characterized by centrally placed nuclei in muscle fibers on biopsy.
  • Inheritance:
    • X-linked recessive.
    • Autosomal dominant.
    • Autosomal recessive.

    Forms of Centronuclear Myopathies

    1. X-Linked Recessive CNM (Myotubular Myopathy)

      • Gene: MTM1 (Myotubularin).
      • Pathophysiology: Impairment in signal transduction for late myogenesis and excitation-contraction coupling.
      • Onset: In utero or neonatal.
      • Clinical Features:
        • Severe neonatal hypotonia ("floppy infant syndrome").
        • Facial diplegia and feeding/respiratory difficulties.
        • Thin ribs, contractures (hips, knees), cryptorchidism.
        • Ophthalmoplegia.
        • Pregnancy may be complicated by polyhydramnios.
      • Prognosis:
        • High neonatal mortality.
        • Survivors require permanent respiratory support.
      • Histological Features:
        • Small type 1 fibers with centrally placed nuclei resembling fetal myotubes.
      • Carriers:
        • Obligate carriers usually asymptomatic.
        • Muscle biopsy changes in up to 50% of carriers.
        • Rare manifesting carriers due to skewed X-inactivation.
    2. Autosomal Dominant CNM

      • Gene: Dynamin 2 (DNM2).
      • Onset: Variable (congenital to adult).
      • Clinical Features:
        • Weakness:
          • Neck flexors, facial muscles.
          • External ophthalmoplegia and ptosis.
        • Wide range of severity; severe forms often linked to de novo mutations.
      • Histological Features:
        • Centralized nuclei.
        • Radial sarcoplasmic strands on oxidative stains.
      • Additional Cause: Mutations in Amphiphysin 2 (BIN1).
        • Rare variant with similar features.
    3. Autosomal Recessive CNM

      • Genes:
        • RYR1 (Ryanodine receptor).
        • BIN1 (Amphiphysin 2).
        • SPEG (Striated muscle preferentially expressed protein kinase).
      • Clinical Features:
        • Onset in infancy or early childhood.
        • Respiratory distress, hypotonia, weak cry, difficulty sucking.
        • Ophthalmoplegia, ptosis, and facial diplegia.
        • Skeletal issues:
          • Delayed motor milestones.
          • Development of contractures and scoliosis.
        • Cardiac involvement in SPEG-related CNM:
          • Associated with dilated cardiomyopathy.
      • Histological Features:
        • Centralized nuclei.
        • Radial sarcoplasmic strands (less apparent in younger children).

    Login to Read More

    Related Articles

    Multiminicore Disease
    Central Core Disease (CCD)
    Nemaline Myopathy (NM)
    Congenital Myopathies